Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Randomized Trial to Evaluate the Effect of Recombinant Herpes Zoster Vaccine on Major Adverse Cardiovascular Events and Dementia in Adults Aged 65 Years or Above

NCT07485283 is registered in ClinicalTrials.gov with Tor Biering-Sørensen as lead sponsor.

NCT NCT07485283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07485283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Randomized Trial to Evaluate the Effect of Recombinant Herpes Zoster Vaccine on Major Adverse Cardiovascular Events and Dementia in Adults Aged 65 Years or Above
Lead sponsor
Tor Biering-Sørensen
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 28, 2026
Completion date
June 30, 2029
Enrollment
168,460 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, dementia